Carboplatin dosing in obese patients

1) Carboplatin dosing at the centre used Calvert's formula for calculating AUC and Cockcroft-Gault's formula for estimating glomerular filtration rate. 2) Cockcroft-Gault's formula employed actual body weight and ideal adjusted body weight in similar proportions. 3) The ideal adjusted body weight was more commonly used in patients with higher obesity and diabetes. 4) In the general population, the developmental trend of toxicity during treatment was greater in the group dosed by actual body weight, reaching significant differences in thrombopenia, neutropenia, GOT elevation, hyporexia and myalgias. 5) Major diagnoses in the present study were ovarian cancer and non-small cell lung cancer. The effectiveness in terms of overall survival and progression-free survival, comparing the groups dosed by actual body weight and ideal adjusted body weight within each pathology did not show statistically significant differences.

Authors

Institutions

Publication Details

Journal
Journal of Oncology Pharmacy Practice
Published
2024-11-04
DOI
https://doi.org/10.1177/10781552241292503
Primary Topic
Chemotherapy-induced organ toxicity mitigation
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Carboplatin dosing in obese patients

Raquel Olmos-Jiménez, Alberto Espuny-Miró, Cristina Ramírez-Roig, María Sacramento Díaz-Carrasco
Journal of Oncology Pharmacy Practice
Chemotherapy-induced organ toxicity mitigation
article

Carboplatin dosing in obese patients

Raquel Olmos-Jiménez, Alberto Espuny-Miró, Cristina Ramírez-Roig, María Sacramento Díaz-Carrasco
article en

Abstract

1) Carboplatin dosing at the centre used Calvert's formula for calculating AUC and Cockcroft-Gault's formula for estimating glomerular filtration rate. 2) Cockcroft-Gault's formula employed actual body weight and ideal adjusted body weight in similar proportions. 3) The ideal adjusted body weight was more commonly used in patients with higher obesity and diabetes. 4) In the general population, the developmental trend of toxicity during treatment was greater in the group dosed by actual body weight, reaching significant differences in thrombopenia, neutropenia, GOT elevation, hyporexia and myalgias. 5) Major diagnoses in the present study were ovarian cancer and non-small cell lung cancer. The effectiveness in terms of overall survival and progression-free survival, comparing the groups dosed by actual body weight and ideal adjusted body weight within each pathology did not show statistically significant differences.

Journal of Oncology Pharmacy PracticeVol. 32(2)
Hospital Universitario Virgen de la Arrixaca (ES)
Good health and well-being
Openalex Percentile: Top 68%
Chemotherapy-induced organ toxicity mitigation
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Carboplatin dosing in obese patients — Raquel Olmos-Jiménez, Alberto Espuny-Miró, et al. · Journal of Oncology Pharmacy Practice (2024) | TGRS Research Map | TGRS